Enlitic (ASX:ENL) has completed technical validation of its Ensight medical imaging data standardisation platform on Oracle Cloud Infrastructure, leveraging AMD EPYC processors.
The validation tested Ensight's performance, reliability, and scalability across a modern cloud environment to support diverse clinical, operational, and research workflows.
Using anonymised medical imaging datasets representing a range of anatomical regions and real-world clinical scenarios, the testing confirmed that Ensight consistently executes data standardisation and normalisation functions, maintains stable performance, and integrates seamlessly with OCI storage and managed database services.
These results align with performance achieved on previous infrastructure, providing confidence in Ensight’s reliability at scale.
The validation demonstrates that healthcare providers and research organisations can deploy Ensight on OCI while meeting strict performance, security, and scalability requirements.
"Our work with AMD and Oracle has validated that Ensight performs as intended on a modern, scalable cloud platform," said Michael Sistenich, CEO of Enlitic.
Tony Nunes, Senior Manager at AMD, noted that the collaboration highlights how AMD EPYC processors can support demanding medical imaging and AI workloads.
Dan Spellman, Vice President at Oracle, added that the validation underscores OCI’s ability to deliver secure, high-performance cloud infrastructure for large-scale healthcare data operations.
At the time of reporting, Enlitic's share price was $0.020.